Corgentech

United States

series-c-plus

Stage

About

Corgentech was a US biopharmaceutical company focused on drug development for cardiovascular diseases. According to the source, Corgentech was listed on NASDAQ in 2004.

Explore Corgentech's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.